ASEQ-EHAQ

L'Association pour la santé environnementale du Québec / Environmental Health Association of Quebec

Kentaro Watai MD PhD

Dr. Watai is a distinguished physician, researcher, and lecturer specializing in allergy, preventive medicine, and respirology. Currently a Lecturer at the Department of Preventive Medicine and Behavioral Sciences at Kindai University Faculty of Medicine in Osaka, Japan, Dr. Watai also serves as Manager of the Center for Immunology and Allergy at Shonan Kamakura General Hospital and as a Visiting Researcher at Sagamihara National Hospital.

Education & Medical Training

Dr. Watai earned a medical degree (M.D.) from Kumamoto University in 2010 and later completed a Ph.D. at Juntendo University in 2018. Their career has been dedicated to advancing clinical research and patient care in allergy and respiratory diseases, with over a decade of hands-on experience in leading medical institutions across Japan.

Professional Experience

✔ 2010-2012 – Resident Physician, Sagamihara National Hospital
✔ 2012-2020 – Allergy & Respiratory Physician, Sagamihara National Hospital
✔ 2020-2022 – Chief of the Allergy Department, Sagamihara National Hospital
✔ 2022-Present – Manager, Center for Immunology and Allergy, Shonan Kamakura General Hospital
✔ 2022-Present – Visiting Researcher, Sagamihara National Hospital
✔ 2024-Present – Lecturer, Department of Preventive Medicine and Behavioral Sciences, Kindai University Faculty of Medicine

Research Contributions & Areas of Expertise

Dr. Watai’s research focuses on allergy, respiratory health, and preventive medicine, with significant contributions in the study of multiple chemical sensitivity (MCS). Their work has examined key factors related to MCS, including:
–  Environmental exposures and their impact on allergy and respiratory health
–  The role of vaccination history in immune system responses
–  Gut microbiota alterations associated with delivery mode and their influence on allergic diseases

Dr. Watai has led genome-wide association studies (GWAS) and metagenomic analyses, uncovering molecular mechanisms underlying MCS and allergic diseases. Their dedication to integrating clinical practice with advanced research continues to shape the future of allergy, immunology, and preventive medicine in Japan and beyond.